Literature DB >> 3257246

Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation.

G A Syrogiannopoulos1, E J Hansen, A L Erwin, R S Munford, J Rutledge, J S Reisch, G H McCracken.   

Abstract

We evaluated the ability of two Haemophilus influenzae type b (Hib) components, lipooligosaccharide (LOS) and capsular polysaccharide, to provoke meningeal inflammation in rabbits. Intracisternal inoculation of 2 fg-200 ng of LOS produced a dose-dependent increase in concentrations of white blood cells and protein in cerebrospinal fluid, whereas 4 micrograms of Hib capsular polysaccharide did not provoke meningeal inflammation. Preincubation of LOS with a murine monoclonal antibody to Hib LOS did not reduce the potency of the LOS. Incubation of LOS with polymyxin B (which neutralizes LOS by binding to its lipid A region) and deacylation of the LOS with acyloxyacyl hydrolase (a neutrophil enzyme that removes nonhydroxylated fatty acyl chains from lipid A) reduced meningeal inflammation. We demonstrated that purified Hib LOS induced meningeal inflammation in this model and suggest that the lipid A moiety of Hib LOS is principally responsible for this host response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257246     DOI: 10.1093/infdis/157.2.237

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain.

Authors:  M Galdiero; M D'Amico; F Gorga; C Di Filippo; M D'Isanto; M Vitiello; A Longanella; A Tortora
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 2.  Should we use dexamethasone in meningitis? The Meningitis Working Party of the British Paediatric Immunology and Infectious Diseases Group.

Authors: 
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

3.  Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

Authors:  X Sáez-Llorens; H S Jafari; C Severien; F Parras; K D Olsen; E J Hansen; I I Singer; G H McCracken
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay.

Authors:  J Mertsola; R S Munford; O Ramilo; X Sáez-Llorens; M M Mustafa; G H McCracken; E J Hansen
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide-induced meningitis.

Authors:  T O'Reilly; C Ostergaard; J Vaxelaire; O Zak
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

6.  Endotoxin induced damage to the cochlea in guinea pigs.

Authors:  M J Tarlow; S D Comis; M P Osborne
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

Review 7.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat.

Authors:  B Wispelwey; A J Lesse; E J Hansen; W M Scheld
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b.

Authors:  G P Jarosik; J D Sanders; L D Cope; U Muller-Eberhard; E J Hansen
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors:  H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.